For Healthcare Professionals Only.
Journal: The American Journal of Gastroenterology
Validity Period (for CME): September 2026
(click to expand) Information for Doctor CME Category 3A (Self-study)
CME points will be awarded to doctors who submit claims for reading papers from Refereed Journals recommended by SMC or listed in PubMed. Papers must be published within the last 2 years. Claims from other publications, such as newsletters, magazines or non-refereed journals, will be rejected. This article serves as a concise overview of the key insights extracted from the original article. Hence, ensure to cite the actual research paper in your CME Cat. 3A claim. Link to the paper is provided in the footnotes. For more information, visit: [Criteria], [List]
(click to expand) Information for Pharmacist CPE Category 3A (Reading)
CPE points will be award to pharmacists who submit claims for reading papers from the list of journals recommended by the SPC if they wish to minimise the rejection of claims for reading non-recognised materials. This article serves as a concise overview of the key insights extracted from the original article. Hence, ensure to cite the actual research paper in your CPE Cat. 3A claim. Link to the paper is provided in the footnotes. For more information, visit: [Main], [Guide, Page 26], [List]
Introduction
Overview of H. pylori Infection:
- A Gram-negative bacterium that adapts to the acidic stomach environment, responsible for chronic gastritis, peptic ulcer disease, and gastric cancer.
- Classified by the WHO as a Group I carcinogen due to its association with gastric cancer.
- Most infected individuals remain asymptomatic, but some develop significant benign or malignant conditions.
Purpose of the Guidelines:
- Developed by the American College of Gastroenterology (ACG) to provide practical, evidence-based recommendations for managing H. pylori infections in North America.
- Includes updates based on rising antibiotic resistance and the advent of new therapies like rifabutin and potassium-competitive acid blockers (PCABs).
Methodology:
- Recommendations were developed using the GRADE methodology to evaluate the quality of evidence and provide strong or conditional recommendations.
- Key concepts are included where GRADE evaluations were not feasible.
Login to read more
